SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Pérez Sala Dolores)
 

Search: WFRF:(Pérez Sala Dolores) > (2020-2023) > Association of Pre-...

  • Butt, JuliaInfections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (author)

Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • 2021-04-20
  • Taylor & Francis,2021
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-182940
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-182940URI
  • https://doi.org/10.1080/19490976.2021.1903825DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Experimental evidence has implicated genotoxic Escherichia coli (E. coli) and enterotoxigenic Bacteroides fragilis (ETBF) in the development of colorectal cancer (CRC). However, evidence from epidemiological studies is sparse. We therefore assessed the association of serological markers of E. coli and ETBF exposure with odds of developing CRC in the European Prospective Investigation into Nutrition and Cancer (EPIC) study. Serum samples of incident CRC cases and matched controls (n = 442 pairs) were analyzed for immunoglobulin (Ig) A and G antibody responses to seven E. coli proteins and two isoforms of the ETBF toxin via multiplex serology. Multivariable-adjusted conditional logistic regression analyses were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association of sero-positivity to E. coli and ETBF with CRC. The IgA-positivity of any of the tested E. coli antigens was associated with higher odds of developing CRC (OR: 1.42; 95% CI: 1.05–1.91). Dual-positivity for both IgA and IgG to E. coli and ETBF was associated with >1.7-fold higher odds of developing CRC, with a significant association only for IgG (OR: 1.75; 95% CI: 1.04, 2.94). This association was more pronounced when restricted to the proximal colon cancers (OR: 2.62; 95% CI: 1.09, 6.29) compared to those of the distal colon (OR: 1.24; 95% CI: 0.51, 3.00) (pheterogeneity = 0.095). Sero-positivity to E. coli and ETBF was associated with CRC development, suggesting that co-infection of these bacterial species may contribute to colorectal carcinogenesis. These findings warrant further exploration in larger prospective studies and within different population groups.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Jenab, MazdaNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France (author)
  • Werner, JillInfections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (author)
  • Fedirko, VeronikaDepartment of Public Health, Aarhus University, Aarhus, Denmark (author)
  • Weiderpass, ElisabeteDepartment of Epidemiology, Rollins School of Public Health, Emory University, GA, Atlanta, United States (author)
  • Dahm, Christina C.Department of Public Health, Aarhus University, Aarhus, Denmark (author)
  • Tjønneland, AnneExposome and Heredity Team, CESP (Centre de Recherche en Epidemiologie et Santé des Populations), Danish Cancer Society Research Center, Diet, Genes and Environment, Nutrition and Biomarkers (NAB), Copenhagen, Denmark; Department of Public Health, University of Copenhagen, Denmark (author)
  • Olsen, AnjaExposome and Heredity Team, CESP (Centre de Recherche en Epidemiologie et Santé des Populations), Danish Cancer Society Research Center, Diet, Genes and Environment, Nutrition and Biomarkers (NAB), Copenhagen, Denmark; Department of Public Health, University of Aarhus, Denmark (author)
  • Boutron-Ruault, Marie-ChristineCesp (Umr1018), Médecine Université Paris-Saclay, Inserm, Gustave Roussy, Villejuif, France (author)
  • Rothwell, Joseph A.Cesp (Umr1018), Médecine Université Paris-Saclay, Inserm, Gustave Roussy, Villejuif, France (author)
  • Severi, GianlucaCesp (Umr1018), Médecine Université Paris-Saclay, Inserm, Gustave Roussy, Villejuif, France; Department of Statistics, Computer Science and Applications (DISIA), University of Florence, Italy (author)
  • Kaaks, RudolfDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (author)
  • Turzanski-Fortner, RenéeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (author)
  • Aleksandrova, KrasimiraDepartment of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke, Germany (author)
  • Schulze, MatthiasDepartment of Molecular Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany (author)
  • Palli, DomenicoInstitute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy (author)
  • Pala, ValeriaEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy (author)
  • Panico, SalvatoreDipartimento Di Medicina Clinica E Chirurgia, Federico II University, Naples, Italy (author)
  • Tumino, RosarioCancer Registry and Histopathology Department, Provincial Health Authority (ASP 7), Ragusa, Italy (author)
  • Sacerdote, CarlottaUnit of Cancer Epidemiology, Città Della Salute E Della, Scienza University-Hospital, Turin, Italy (author)
  • Bueno-de-Mesquita, BasFormer Senior Scientist, Dept. For Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands; Former Associate Professor, Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, Netherlands; Dept. Of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom; Dept. Of Social Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (author)
  • Van Gils, Carla H.Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands (author)
  • Gram, Inger TorhildDepartment of Community Medicine, University of Tromsø, Arctic University of Norway, Tromsø, Norway (author)
  • Lukic, MarkoDepartment of Community Medicine, UiT, The Arctic University of Norway, Tromsø, Norway (author)
  • Sala, NúriaUnit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program and Translational Research Laboratory, Catalan Institute of Oncology (ICO), Biomedical Research Institute (IDIBELL), Barcelona, Spain (author)
  • Sánchez Pérez, María JoséEscuela Andaluza De Salud Pública (EASP), Granada, Spain; Instituto De Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Centro De Investigación Biomédica En Red De Epidemiología Y Salud Pública (CIBERESP), Madrid, Spain; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain (author)
  • Ardanaz, EvaNavarra Public Health Institute, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; CIBER Epidemiology and Public Health CIBERESP, Madrid, Spain (author)
  • Chirlaque, María-DoloresDepartment of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain (author)
  • Palmqvist, RichardUmeå universitet,Patologi(Swepub:umu)ripa0001 (author)
  • Löwenmark, ThyraUmeå universitet,Patologi(Swepub:umu)thlo0020 (author)
  • Travis, Ruth C.Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom (author)
  • Heath, AliciaDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom (author)
  • Cross, Amanda J.Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; Cancer Biology and Therapeutics Group, School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland (author)
  • Freisling, HeinzNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France (author)
  • Zouiouich, SemiNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France (author)
  • Aglago, ElomNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France (author)
  • Waterboer, TimInfections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (author)
  • Hughes, David J.Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France (author)
  • Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, GermanyNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France (creator_code:org_t)

Related titles

  • In:Gut microbes: Taylor & Francis13:1, s. e1903825-1-e1903825-141949-09761949-0984

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view